the examination of the specificity of M-MSV-immune cytolytic T lymphocytes. In the present report, we describe our finding that infectious type C virus can induce a secondary cytotoxic response, and explore the possibility that this technique can further be used to elucidate the specificity of cytotoxic T lymphocytes.
Materials and Methods Mice. C57BL/6N (B6) mice were obtained from the Rodent and Rabbit Production Section, Division of Research Services, National Institutes of Health, Bethesda, Md.
Tumors. Primary tumors were induced by the M-MSV (>104 focus-forming units) in B6 mice as described previously (2) . Usually, the tumors arose 6-7 after inoculation, reached maximum size on days 11-14, and regressed by days [22] [23] [24] [25] . For studies of the secondary cytotoxic response, spleen cells were obtained from mice 30-50 d after inoculation with M-MSV.
Target Cells. The characteristics and origins of the cell lines employed in this study are given in Table I (3, 7, 11) . They were grown as stationary suspension or monolayer cultures in RPMI-1640 medium (Grand Island Biological Co., Grand Island, N.Y.) containing 10% fetal calf serum (FCS), I00 #g/ml streptomycin, 100 U/ml penicillin, and 50 #g/ml gentamicin (hereafter referred to as RPMI-1640-10% FCS) (12) . The in vivo passaged tumor lines were maintained by serial passage in normal histocompatible recipients. The respective cell lines were assayed for the expression of viral antigens by competition radioimmunoassay (7) .
Viruses. M-MSV was prepared from a stock originally obtained from Dr. J. B. Moloney, National Cancer Institute (NCI), Bethesda, Md., and maintained in our laboratory (2) . Moloney MuLV clone IC (M-MuLV clone IC) from NIH/3T3 cells, Rauscher MuLV (RMuLV) from JLS-V9 cells, Gross-MuLV and BALB virus-1 from NIH/3T3 cells, AKR-MuLV from AKR mouse embryo fibroblasts (originally obtained from Dr. W. P. Rowe, National Institute of Allergy and Infectious Diseases [NIAID] , Bethesda, Md.), BALB virus-2 from human A673 cells, feline leukemia virus (FeLV), and baboon type C virus were obtained from the Viral Oncology Program of the National Cancer Institute through the courtesy of Dr. J. Gruber. These viruses, except for M-MSV, were purified by double sucrose density gradient uhracentrifugation and stored at -70°C until use. Ecotropic M-MuLV clone H, originally isolated by Dr. Janet Hartley, NIAID, Bethesda, Md. (13) , and a variant (duahropic) of MMuLV clone 83 (13) Md. (14) . BALB B-tropic virus (WN 1802B), originally isolated by Dr. Janet Hartley, was propagated on SC-1 cells in McCoy's 5A medium containing 10% FCS and was obtained from Dr. Robert H. Bassin, NCI, Bethesda, Md. (15) . The characteristics of the virus used in the present study are given in Table II .
Irradiation of Virus with Ultraviolet (UV)-light. Irradiation of infectious virus with UV-light
(General Electric Co., Lamp Parts & Equipment Sales Operation, Cleveland, Ohio) was performed as described previously (16) . In brief, virus was diluted in 1 ml of phosphate-buffered saline, placed onto a watch glass, and then irradiated with UV-light at 60 ergs/mm 2 per s. Treatment for 40 s (total 2,400 ergs/mm 2) was shown to inactivate 1 log of infectious virus, as determined by XC syncytial plaque assay (16) and the S+L-focus assay on FG-10 (17).
Virus Infectivity Assay. Eeotropic and dualtropic M-MuLVs were assayed according to the method of Bassinet al. (17) , using the S + L -focus assay on FG-10 cells (kindly provided by Dr. R. Bassin, NCI) that had been pretreated with 20 ~g/ml DEAE-dextran. Assays for xenotropic virus, FeLV, and baboon type C virus were done by the focus assay in the S + L -mink cells (18) (kindly given by Dr. J. Hartley, NIAID) or the S + L -cat cell 81 (19) (obtained from Dr. P. Fischinger, NCI) in the presence of polybrene (2 pg/ml). The results of the S + L -assay are given as focus-inducing units (FIU) per milliliter. M-MSV was titrated on 3T3FL (given by Dr. A. Rein, NCI) in the presence of an optimal concentration of helper virus, by the method of Bassinet al. (20) , with the titer being expressed as focus-forming units per milliliter.
In Vitro Generation of a Secondary Cytotoxic Response. Spleens were removed aseptically from M-MSV-immune or normal animals and minced. The resulting single cell suspension was passed through sterile gauze and suspended in Dulbecco's modified minimal essential medium (DMEM) containing 10% FCS (lot RG1808, Reheis Chemical Co., Chicago, Ill.) 50/.tM 2-mercaptoethanol, 2 mM glutamine, 100 U/ml penicillin, 100 pg/ml streptomycin, 34/~g/ml L-asparagine, 116 /~g/ml arginine-HCl, and 10 pg/ml folic acid (hereafter referred to as complete DMEM). Secondary cell-mediated eytotoxicity was generated in vitro using a modification of the method described by Plata et al. (8) . Briefly, unseparated immune spleen cells (ISC), suspended in complete DMEM, were adjusted to a final concentration of 5 × 106 cells/ml. Tumor cells to be used as stimulators were treated with 100/xg/ml mitomycin C/10 7 cells (Sigma Chemical Co., St. Louis, Mo.) for 60 min at 37°C and washed three times with RPMI-1640-10% FCS. For culture, 5 × l0 s immune spleen cells were mixed with different concentrations of purified virus, tissue culture supernates containing infectious virus or 2 × 105 mitomycin C-treated tumor cells in 2.0 ml of complete DMEM and dispensed in muhiwell dishes (FB-16-24-TC, Linbro Chemicals, Hamden, Conn.). In a preliminary experiment, we found that with intact tumor cells as in the stimulus, the optimal responding cell to stimulator cell ratios were 25:1 and 20:1. Each group consisted of at least four cultures. Cultures were incubated at 37°C in a humidified atmosphere containing 5% CO2 in air. After 5 d in culture, lymphocytes were harvested and used as effector cells in a 4-h 51Cr-release assay.
SICr-release Assay. The procedure was described previously (9, 10) . Varying numbers of effector cells were mixed with 5 × 10 a 5aCr-labeled target cells in a final 0.2-ml vol in microtiter plates with U-shaped wells (Linbro Scientific Co.). The plates were then centrifuged at 65 g for 2 min and were incubated at 37°C for 4 h. Supernates were then harvested with the Titertek Supernatant Collecting System (Flow Laboratories, Inc., Rockville, Md.), and the percent cytotoxicity was determined as follows:
cpm of test supernate -cpm of autologous control % cytotoxicity = × 100. total cpm incorporated into cells % specific cytotoxicity = % cytotoxicity of immune spleen cells stimulated with an antigen or a supernatant-containing infectious virus -% cytotoxicity of immune spleen cells cultured alone or with supernate from uninfected cells.
The percent cytotoxicity of immune spleen cells cultured alone (unstimulated) was 5.0 :!: 4.4 (mean + standard deviation) for 20 experiments. An autologous control, with unlabeled target cells in place of lymphocytes, was used to measure the spontaneous release. Each experimental group was tested in quadruplicate.
Elimination of T Lymphocytes. AKR anti-C3H, anti-Thyl.2, was prepared as previously described (21) . To eliminate T lymphocytes, 10-20 × 106 effector cells were incubated with undiluted AKR anti-C3H Thyl.2 serum (0.3 ml) for 30 min at room temperature. Next, the cells were washed once with RPMI-1640 medium, resuspended in a 1:2 dilution of normal rabbit serum (Grand Island Biological Co.) (preselected for lack of toxicity against mouse lymphocytes) as a source of complement, and incubated for 45 min at 37°C. After being washed three times, the cells were then counted and used in the test.
Results
Induction of a Cytotoxic Response: Tumor Cells vs. Virus. As has been reported previously (8) (9) (10) , M-MSV-immune spleen cells could be restimulated in vitro with the relevant intact tumor cells to produce a potent secondary cytotoxic response 5 d after the initiation of culture (Table III) . In addition to the routine use of MBL-2 tissue culture cells as the stimulus, we decided to investigate whether supernatant fluids from cultures of MBL-2 could substitute for the intact tumor cells. As shown in Table III , the supernate from MBL-2 cultures was as good as or better than intact tumor cells for inducing a secondary response. Normal spleen cells were not stimulated to produce a cytotoxic response with either MBL-2 or culture supernates from MBL-2 cells. Furthermore, the stimulated immune cells did not react appreciably or consistently against RLc~I, a target that does not contain cross-reacting antigens.
These results prompted us to investigate the possibility that a virus released from MBL-2 was responsible for the induction of this response, because the supernate from MBL-2 tissue cultures was found to contain >105 FIU/ml of infectious ecotropic MuLV. M-MuLV clone IC was tested for its ability to induce a secondary cytotoxic response. Addition of 3 × 109 virus particles per culture stimulated high levels of cytotoxicity in spleen cells from animals 30 d after MSV inoculation. As with the supernate from MBL-2, no cytotoxic reactivity was seen when normal spleen cells were used as the responders. Table IV , significant cytotoxicity was induced by M-MuLV clone IC by day 4, and by day 5 had reached a peak. Thereafter, the cytotoxicity induced by M-MuLV clone IC decreased. These kinetics were comparable to those observed in cultures containing mitomycin C-treated MBL-2 as the stimulus.
Nature of the Effector Cells.
Although it has been established that T lymphocytes are the effector cells generated when intact tumor cells are used as the stimulus (8-10), it was important to determine whether the effector cells generated in a secondary cytotoxic response by M-MuLV clone IC were also T lymphocytes. To test this, M-MSV-immune spleen cells obtained after 5 d of cuhure with M-MuLV clone IC were treated with anti-Thyl.2 plus complement before assaying their cytolytic activity on MBL-2. As shown in Table V , treatment with anti-Thyl.2 plus complement, but not complement alone, completely abolished the cytolytic activity, indicating that the effector cells generated in the secondary cytotoxic response by M-MuLV were T lymphocytes. Similar results were obtained when tissue culture supernate from MBL-2 was used as the stimulus (data not shown).
Specificity of Cytolytic T Lymphocytes Generated by Intact MBL-2 or M-MuLV Clone IC.
To determine the specificity of the cytolytic T lymphocytes, a wide panel of target cells was employed in a 4-h 51Cr-release assay. As shown in Table VI , cytolytic T lymphocytes generated by M-MuLV clone IC were capable oflysing MBL-2, RBL- (8, 9, 22, 23) , the cytotoxicity observed in the present study was H-2 restricted, because YAC and LSTRA, M-MuLV-induced iymphomas of A and BALB/c mice were not lysed in a 4 h 5aCr-release assay (Table  VI) . Moreover, the fact that good targets (YAC and RLc~I) for NK activity (24) were also not killed significantly by cytolytic T lymphocytes shows that the effector cells were immune T lymphocytes but not NK cells. This result was further confirmed by a cold target inhibition study in which experiments were performed using labeled MBL-2 target cells and unlabeled competitive inhibitor cells including MBL-2 and YAC. Only MBL-2 inhibitor cells abrogated the cytolysis of MBL-2 in a dosedependent manner whereas YAC did not inhibit (data not shown).
The Role of the Infectivity of M-MuL V in Induction of a Secondary Cytotoxic Response. In the above experiments, infectious M-MuLV clone IC was shown to induce a secondary cytotoxic response. It was important to determine if infectivity was required for induction of the response, because previous reports with other nononcogenic viruses were conflicting. Ertl et al. (25) reported a requirement for infectious vaccinia virus to induce virus-specific cytotoxic T lymphocytes in vivo. However, inactivated influenza virus (26) and Sendai virus (27, 28) were able to induce cytotoxic responses in vitro. Experiments were therefore performed to investigate whether inactivated MMuLV was able to induce a secondary cytotoxic response against MBL-2. The results shown in Fig. 1 A indicated that when the infectious virus was exposed to UV-light for a period resulting in a decrease to 1/1,000 of the original infectivity, 1,000-fold more virus particles were required to induce the same degree of the cytotoxicity. We considered the possibility that this treatment somehow rendered the infectious virus immunologically inactive (e.g., by conformational change of the antigens). Therefore, various doses of UV-irradiation were tested and the results are shown in Fig. 1 B. Treatment of the infectious M-MuLV for 40 s (2,400 ergs/mm 2) or 1 min 20 s (4,800 ergs/mm2), which decreased infectivity by 1 or 2 logs, respectively, decreased the ability of the virus to induce a secondary cytotoxic response by ~ 12-to 50-fold and 100-to 300-fold, as compared to the untreated virus control. Taken together, these results suggest that there is a close correlation between the infectivity of M-MuLV and the ability to induce a secondary cytotoxic response in this system. (Table VII) , low but significant levels of cytotoxicity were detectable. Recently, some variants of M-MuLV, which were shown to be recombinants in the env gene region between ecotropic M-MuLV and a xenotropic virus, have been isolated (13, 14) . It was of interest to determine whether these variants of M-MuLV (M-MuLV clone 83, HIX-FEF, or HIX-RD) as well as ecotropic M-MuLVs clone IC and clone H could induce a secondary cytotoxic response by M-MSV-immune spleen cells. The results shown in Table IX indicate that two ecotropic M-MuLVs consistently showed an ability to induce a secondary cytotoxic response. However, M-MuLV
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TABLE VII Ability of Ecotropic Viruses To Induce a Secondary Cytotoxic Response by M-MSV-immune Spleen Ceils
Percent specific cytotoxicity (+ SE)* Exp.
Virus clone 83, HIX-FEF, and HIX-RD were found to be inactive, suggesting that the env gene product, gp70, was important in this response.
Aoki et al. (29) had reported that SIRC cells infected with some xenotropic viruses inhibited the cytolysis by anti-M-MSV cytolytic T lymphocytes. Therefore, an experiment employing xenotropic BALB virus-2 was performed. As shown in Table   X , BALB virus-2 was inactive, whereas M-MuLV clone IC was able to induce a secondary cytotoxic response in the same experiment. We also evaluated whether type C viruses derived from other species could generate a secondary cytotoxic response by M-MSV-immune spleen cells. The results shown in Table XI First, the concentration of MBL-2 tumor cells that we used to generate the supernate was 5-to 10-fold higher than the concentration employed in the secondary response culture and, therefore, the increase in cell concentration could have yielded higher titers of virus in the supernate than are normally produced in the secondary response cultures. In addition, we have recently found that infectious virus is most effective at inducing a secondary response when added during the first 24 h of culture (T. Taniyama. Unpublished observations.). Therefore, it would be important to have high concentrations of virus during the early phase of the in vitro secondary response and further testing would have to be performed to determine whether the rate of virus production by the tumor cells was sufficient to meet these requirements. Second, although LSTRA induces a potent secondary cytotoxic response in syngeneic BALB/ c M-MSV-immune spleen cells, it does not as readily stimulate development of cytotoxicity to tumor-associated antigens in B6 M-MSV-immune spleen cells. If the virus produced by the tumor cells were the only stimulus, then one might expect the same cells to be an equally capable inducer for both responding populations. However, MHC products on the envelope of the released viruses might contribute to differences in responses by syngeneic vs. allogeneic responding cells, perhaps by influencing the rate at which the virus was adsorbed to the cells. Alternatively, the situation may be the same as mentioned in the first point, namely that there is not enough virus produced by the tumor cells (LSTRA in this case) during the early phase of the culture, to act as an efficient stimulus. Regardless of the explanation, it appears that the tumor cells are more restricted than infectious virus in their ability to induce a secondary response and also that the sequence of events after stimulation by tumor cells may be different from that when infectious virus is the inducing agent.
The results in the present study also suggest that for virus to be able to induce a secondary cytotoxic response, it must be infectious. When M-MuLV was irradiated with UV-light at doses which caused a decrease in infectivity of either 1, 2, or 3 logs as determined by the XC-plaque assay, the ability of irradiated M-MuLV to induce a secondary cytotoxic response decreased in parallel to the infectivity. Although this result suggests that there was an association between infectivity of the virus and its ability to induce a secondary cytotoxic response, at least two other possible mechanisms for this can be considered. The first is that the UV irradiation rendered the virus immunologically inactive. Although this is certainly possible, it is not likely because it has been shown that UV irradiation mainly affected RNA species and not proteins (30) . The second alternative is that infection with, and replication of, MMuLV, and not just adsorption of virus, was required for the formation of immunologically active antigens on the cell surface. Although low doses of infectious MMuLV could induce detectable cytolytic T lymphocytes, little cytotoxicity was generated in the presence of 103-to 104-fold higher concentrations of virus that had Table VIII . :~ As in Table VIII . § As in Table VIII. been UV-irradiated to reduce the titer by 7 logs (data not shown). In recent experiments using purified M-MuLV gp70 (5/~g/ml), we have been unsuccessful in inducing a secondary cytotoxic response (unpublished data), although it may be possible to induce a response with much higher concentrations of M-MuLV gp70. Therefore, infectivity of virus appears to be necessary for the induction of a secondary cytotoxic response. Our results should be compared to those by Braciale and Yap (26) and Others (27, 31) . Inactivated Sendai virus or virion proteins were shown to induce virus-specific cytotoxic responses (27, 28) , and to sensitize target cells for lysis by cytolytic T lymphocytes (27, 31) . Braciale and Yap also found that influenza virus inactivated by UV light was able to induce a secondary cytotoxic response but failed to sensitize target cells for lysis (26) . Nevertheless, it should be noted that Sendai virus possesses a fusion protein which allows for the efficient integration of virion antigens into cell surface cytoplasmic membranes (32) . Thus, the requirement for infectivity with M-MuLV suggests that absorption of the inactivated virus is not sufficient for immunogenicity. It seems likely that integration of M-MuLV into the cell membranes of responding cells or accessory cells, via infection, is needed for the formation of stimulatory antigens. These results are compatible to those of Ertl et al. (25) and Braciale and Yap (26) who showed that infectivity of viruses was required for the induction of cytolytic T lymphocytes in vivo by using vaecinnia and influenza viruses. Currently, we are investigating which types of the cells are infected with M-MuLV.
In some other studies involving cytotoxic reactivity against type C viral antigens, it appears that noninfectious materials were capable of inducing an in vitro secondary cytotoxic response. Alaba and Law (33) have recently reported that spleen cells from mice immunized with antigen solubilized from the plasma membrane of a Rauscher virus-induced lymphoma could be restimulated in vitro with the same antigen to become cytotoxic. Bruce et al. (34) found that disrupted MuLV could stimulate a secondary response by spleen cells from rats immunized with a Gross virus-induced lymphoma. In contrast, we have previously tested several materials (other than Although tumor immune responses in the MSV system have been extensively studied in many laboratories, there is no agreement on the nature of the antigenic specificities of the cellular response. Gomard et al. (23) examined the nature of the cell surface antigens, and found that Friend-Moloney-Rauscher-like antigens appeared to be major antigenic determinants. Herberman et al. (3) reported that the surface antigens recognized by anti-M-MSV cytolytic T lymphocytes were related to the expression of endogenous type C virus. Furthermore, Aoki et al. (29) , using a cold target cell inhibition assay, reported that xenotropic virus-producing SIRC cells could inhibit the anti-M-MSV response. Gorczynski and Knight (35) found p30 to be one of the antigenic determinants. More recently, Enjuanes et al. (7) found that the primary anti-M-MSV cytotoxic response was specific for M-MuLV, and especially for its envelope gp70, as determined by ~tCr release inhibition by purified virion components. In the present study, we examined the specificity of the cytotoxic response in both the induction and effector phases. Effector cells generated by MMuLV clone IC could lyse efficiently MBL-2, EL-4(G+), B6-MEF-M-MSV, and B6-MEF-M-MuLV, but did not significantly affect EL-4(G-), YAC, RLdl, RDM-4, B6-MEF, B6-MEF-B-tropic, B6-MEF-F-MuLV, and E(3G2, thus indicating that the determinant(s) recognized by cytolytic T lymphocytes was closely associated with MMuLV but not with a variety of other murine type C oncornaviruses. These results (39) . Thus, although EL-4(G+)expresses serologically detectable GCSA, it seems possible that EL-4(G+) contains an endogenous MuLV closely associated to M-MuLV, instead of or in addition to Gross-MuLV.
In the induction phase, only ecotropic M-MuLVs clone IC and clone H were able to induce a secondary cytotoxic response by M-MSV-immune spleen cells. In contrast, AKR-MuLV, Gross-MuLV, BALB-B-tropic virus, and BALB virus-1 failed to induce such responses, indicating that this response was not a result of these characterized endogenous murine type C viruses. However, it is still possible that a particular endogenous type C virus was responsible for the induction of this response. When RMuLV was used as the stimulus, low but significant levels of cytotoxicity could be induced, thus indica~ting some cross-reactivity, perhaps of a minor antigenic determinant(s), between M-and R-MuLVs, because type-, group-and interspecies-specific determinants of gp70 and p30 have been found by radioimmunoassay (40) . Thus, it appears from the above results that the induction of in vitro secondary cytotoxic responses by virus is specific for M-MuLV and related viruses. Thus, by studying the ability of infectious viruses to induce a secondary response, we have found that both the induction and effector phases of the in vitro secondary cytotoxic response in the M-MSV system are strongly associated with the type-specific determinants of M-MuLV gpT0. Furthermore, this experimental approach should facilitate the detailed analysis of the cell-mediated cytotoxic response to oncornaviruses.
Summary
We have developed a system to induce oncornavirus-specific secondary cytotoxic response in vitro. When Moloney strain of murine sarcoma virus-immune spleen cells were cultivated with purified infectious Moloney murine leukemia virus (M-MuLV) or with supernates of tissue culture cells containing infectious virus, a virus-specific secondary cytotoxic response directed against type-specific determinant(s) of MMuLV was generated in vitro, as determined by a 4-h mCr-release assay. The effector cells were susceptible to the treatment with anti-Thyl.2 plus complement, but were unrelated to natural killer cells (NK), because they could not lyse some target cells that are highly sensitive to NK activity. This response was primarily (or largely) typespecific for M-MuLV in both the induction phase and the interaction between effector cells and target cells. Furthermore, a product of the env gene of M-MuLV, perhaps gp70, appeared to be responsible for this response, because viruses with recombinations in the env gene between ecotropic M-MuLV and a xenotropic virus failed to induce a response. When infectious M-MuLV was exposed to UV-light at different doses, the ability of UV-treated M-MuLV to induce a secondary cytotoxic response decreased in parallel with infectivity, indicating that infectivity was necessary for the induction of this response.
